Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
7.95
-0.18 (-2.21%)
At close: Jun 23, 2025, 3:59 PM
7.96
0.13%
After-hours: Jun 23, 2025, 04:04 PM EDT
-2.21% (1D)
| Bid | 7.75 |
| Market Cap | 166.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -20.16M |
| EPS (ttm) | -1.13 |
| PE Ratio (ttm) | -7.04 |
| Forward PE | -7.54 |
| Analyst | Buy |
| Ask | 10 |
| Volume | 107,373 |
| Avg. Volume (20D) | 128,775 |
| Open | 8.02 |
| Previous Close | 8.13 |
| Day's Range | 7.84 - 8.06 |
| 52-Week Range | 4.44 - 11.80 |
| Beta | -0.16 |
About NVCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-46.3%
Nuvectis Pharma shares are trading lower. The comp...
Unlock content with
Pro Subscription
7 months ago
+17.75%
Nuvectis Pharma shares are trading higher after the company reported better-than-expected Q3 EPS results.
